Achieving Targeted Treatment Outcomes in IBD : Episode 7

Opinion

Video

August 6, 2024

Considerations for Choosing Advanced Treatments and Setting Patient Expectations

Author(s):

Silvio Danese, MD, PhD ,Bruce Sands, MD

Gastroenterologist experts discuss the current landscape of biologic treatments for inflammatory bowel disease and the occasional necessity to switch between different biologic agents, while also sharing insights on their preferred treatment sequencing strategies.

EP: 1.Treat-to-target in Inflammatory Bowel Disease

EP: 2.Recommended Targets When Treating Ulcerative Colitis/Crohn’s Disease in Clinic

EP: 3.Transmural Healing and Monitoring in Ulcerative Colitis and Crohn’s Disease

EP: 4.Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease

EP: 5.Suboptimal Treatment of Inflammatory Bowel Disease in Clinical Practice

EP: 6.Unmet Needs and Starting Advanced Treatment in Inflammatory Bowel Disease

EP: 7.Considerations for Choosing Advanced Treatments and Setting Patient Expectations

EP: 8.Combination Therapy in Inflammatory Bowel Disease

EP: 9.Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment Changes

When do you consider starting or switching advanced treatment for UC and CD?
How do you communicate with the patient about starting an advanced treatment?

Related Videos

Gregory Mattingly, MD I St. Charles Psychiatric Associates

Duloxetine for Patients with COPD Suffering from Comorbid Depression

Enhancing Standards for Ethical Responsibilities within Clinical Research

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.